Host cells and their use for producing ribitol and further monosaccharides

US12522848B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12522848-B2
Application numberUS-202017779561-A
CountryUS
Kind codeB2
Filing dateDec 17, 2020
Priority dateDec 18, 2019
Publication dateJan 13, 2026
Grant dateJan 13, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to host cells and their use wherein the host cells are capable of producing D-ribulose and incapable of or have a reduced capability of converting D-ribulose to a molecule other than ribitol, wherein the host cells comprise a heterologous nucleic acid sequence encoding a polypeptide capable of converting D-ribulose to ribitol with a cofactor preference for NADPH.

First claim

Opening claim text (preview).

What is claimed is: 1 . A host cell that is capable of producing D-ribulose, wherein the host cell comprises one or more heterologous nucleic acids encoding a polypeptide capable of converting D-ribulose to ribitol selected from: (a) a nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 7, wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 7, respectively; (b) a nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 9, wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 9, respectively; and (c) a nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 11, wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 38 and 39 of the polypeptide of SEQ ID NO: 11, respectively; wherein the host cell comprises an endogenous gene encoding a polypeptide that is capable of converting D-ribulose to D-arabitol, wherein said endogenous gene is inactivated through deletion of the gene, and wherein the host cell is a yeast cell. 2 . The host cell of claim 1 , wherein the host cell is capable of producing D-ribulose from D-glucose. 3 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 7, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 7, respectively. 4 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 9, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 9, respectively. 5 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 11, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 38 and 39 of the polypeptide of SEQ ID NO: 11, respectively. 6 . The host cell of claim 1 , wherein the yeast cell is Pichia ohmeri. 7 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising SEQ ID NO 7. 8 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising SEQ ID NO 9. 9 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising SEQ ID NO 11. 10 . The host cell of claim 1 , wherein the host cell comprises more than one of the heterologous nucleic acids encoding a polypeptide capable of converting D-ribulose to ribitol. 11 . The host cell of claim 10 , wherein the host cell comprises (a) a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO:7, wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 7, respectively, and (b) a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 9, wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 9, respectively. 12 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 7, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 7, respectively. 13 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 9, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 9, respectively. 14 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 11, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 38 and 39 of the polypeptide of SEQ ID NO: 11, respectively. 15 . A method for producing ribitol comprising culturing the host cell of claim 1 under cell culture conditions, wherein ribitol is produced by the host cell. 16 . The method of claim 15 , further comprising isolating the produced ribitol.

Assignees

Inventors

Classifications

  • for fungi · CPC title

  • C12N9/0006Primary

    acting on CH-OH groups as donors (1.1) · CPC title

  • Yeasts; Culture media therefor · CPC title

  • C12P7/18Primary

    polyhydric · CPC title

  • Oxidoreductases (1.) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12522848B2 cover?
The present invention relates to host cells and their use wherein the host cells are capable of producing D-ribulose and incapable of or have a reduced capability of converting D-ribulose to a molecule other than ribitol, wherein the host cells comprise a heterologous nucleic acid sequence encoding a polypeptide capable of converting D-ribulose to ribitol with a cofactor preference for NADPH.
Who is the assignee on this patent?
Danstar Ferment Ag
What technology area does this patent fall under?
Primary CPC classification C12N9/0006. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).